Tobias Appenzeller

Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA.

Synthes, Inc. engages in the development, production, and marketing of instruments, implants, as well as biomaterials for surgical fixation, correction, and regeneration of the human skeleton and its soft tissues. The company was founded in 1999 and is headquartered in Solothurn, Switzerland.

ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland.

Artiman Management LLC (Artiman Ventures) is a venture capital firm founded in 2001 by Amit Dilip Shah. The firm is headquartered in East Palo Alto, California.

Cadila Pharmaceuticals Ltd. manufactures and distributes pharmaceutical products. The company is involved in manufacturing pharmaceutical products, new drug discovery, novel drug delivery, analytical research, biosynthesis and genetic engineering. It also manufactures cardiovascular, gastrointestinal, anti inflammatory, antibiotics, vaccines, anti-diabetic and vitamin drugs. The company was founded in 1951 by Indravadan Ambalal Modi and is headquartered in Ahmedabad, India.

Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers, Inc. is a South African company that provides accounting, auditing, and bookkeeping services. The company is based in Sunninghill, South Africa.

Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland.

Spirig Pharma AG manufactures and distributes pharmaceutical products. The company was founded in 1948 and is headquartered in Egerkingen, Switzerland.

Ulrich Jüstrich Holding AG is an investment holding private company based in Walzenhausen, Switzerland. and has subsidiaries in Switzerland and France. The Swiss company operates as an investment holding company.

Acino Pharma AG engages in the development, production, and distribution of chemical and pharmaceutical products. It also acquires, manages, and sells participating interests in firms, real estate, and intellectual property rights. The company was founded in 1961 and is headquartered in Liesberg, Switzerland.

Hänseler AG manufactures and wholesales pharmaceutical products. It offers liquid, semi-solid and solid drug forms and drug substances in conformity with GMP. The firm manufactures galenical, which includes liquid, semi-solid and solid drug forms; and liquid extracts and tinctures. The company was founded by Edwin Hanseler in 1975 and is headquartered in Herisau, Switzerland.

Aditazz, Inc. provides designing and construction services. Its services include operational modeling through computer simulation and optimization and design, manufacturing and assembly of building components. Aditazz was founded by Deepak Aatresh, Rubel Zigmund and Ward Vercruysee on March 8, 2010 and is headquartered in Brisbane, CA.

Core Diagnostics Pvt Ltd. provides diagnostics for disease stratification and therapy selection. It provides services such as second opinion, customized report, unique tests and doorstep service. The company was founded by Arghya Basu and Zoya Brar and is headquartered in Gurgaon, India.

Nexilis AG is a Swiss medtech company that specializes in providing cost-effective fixation enhancement for any bone screw. The private company's flagship product is the Immediate Stabilisation System (ISS), which is an implantable polymer sleeve that is moulded around the pedicle screw using ultrasonic energy. Nexilis has a culture built around innovative science, precision, and quality, and has engaged in collaborations with renowned institutions to create safe and easy-to-implement solutions for surgeons. The company was founded by Martin Horst and the CEO is Leanna Caron.

OncoStem Diagnostics Pvt Ltd. provides healthcare and medical services. The company is headquartered in Ebene, Mauritius.

The DePuy Synthes Inc. provides orthopaedic and neuro products and services in the areas of joint reconstruction, trauma, spine, sports medicine, neuro, cranio-maxillofacial, power tools and biomaterials. The company was founded in 1895 and is headquartered in Warsaw, IN.

Aurealis Oy operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers. It develops a proprietary technology, which utilizes genetically modulated probiotics that deliver a variety of therapeutic proteins to diseased tissue, thus modulating local immune system and enabling healing. The company was founded by Dirk Weber and Thomas Wirth in 2010 and is headquartered in Kuopio, Finland.

Tata Trusts operates as a philanthropic trust. The private company is based in Mumbai, India.

Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland.

Mavena International AG develops, manufactures, and markets medical care products for the treatment of chronic skin conditions. The company is headquartered in Huneberg, Switzerland.

Strekin AG is a Swiss pharmaceutical company that develops pharmaceuticals, therapeutics, and vaccines. The private company was founded in 2014 and is based in Basel, Switzerland.

Ibex Medical Analytics Ltd. develops and operates medical analysis platform for pathology and cancer diagnostics. The company was founded by Joseph Mossel and Chaim Linhart in 2017 and is headquartered in Tel Aviv-Yafo, Israel.

ImmunOs Therapeutics AG is a company based in Schlieren, Switzerland that pioneers HLA-based therapeutics to create transformational medicines for cancer and inflammation. The Swiss company has identified specific HLA molecules that activate the immune system and is utilizing these molecules as the backbone of novel therapies capable of stimulating both the innate and adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs' lead program is a multi-functional fusion protein that blocks specific LILRB and KIR receptors and activates anti-tumor responses. The company is also using HLA molecules to develop novel therapies to treat inflammatory diseases. ImmunOs is supported by leading international investors, including Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, Biomed Partners, Schroder Adveq, Mission BioCapital, GL Capital, Peak6, Fiscus, and Redalpine. The company was founded by Osiris Marroquin Belaunzaran and Christoph Renner, and the CEO is Sean R. Smith.

Part of Aurealis Oy, Aurealis Pharma AG is a Swiss company that provides scientific research and development services. The company is based in Basel, Switzerland. The company was founded by Juha Matti Yrjänheikki.

Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022.

Versameb AG operates as an preclinical-stage biopharmaceutical company. The company was founded by Friedrich Metzger, Roger Meier and Urs Breitenstein in 2018 and is headquartered in Basel, Switzerland.

Part of Asto CT, Inc., Leo Cancer Care Ltd is a British company that provides upright proton therapy, radiology, and photon therapy solutions for cancer treatment. The company is based in Smallfield, UK. The company's approach is built on research from across the globe, showing the benefits of upright patient positioning and a shift from machine rotation to patient rotation, which is set to change the face of radiation therapy for good. Leo Cancer Care was founded in 2018 by Stephen Kevin Towe and Thomas Rockwell Mackie, with Stephen Kevin Towe serving as the CEO since then.